Results for "consumer data right"
201-210 of 546 results for 'consumer data right'
Using gen AI tools for business? Be aware of the (many) limitations on your IP protections
To assist businesses to make informed decisions about which AI tools to use and for what purposes, we have conducted an in-depth analysis of the terms and conditions applicable to a range of commonly used, off-the-shelf generative AI tools from an intellectual property perspective. ...
Automotive sector outlook: what's driving recent trends
Whether it be consumer guarantees or vehicle emissions, the automotive sector continues to be highly regulated, and the target of scrutiny from regulators and private litigants alike. In this Insight, we reflect on some of the key issues facing the sector. ...
Applying WHS principles to the regulation of AI in the workplace
The regulatory approach to AI in Australia is still in its early stages, with the Federal Government currently consulting on the best way to implement regulation that supports the safe and responsible ...
OAIC's landmark case against Facebook to have major implications on Privacy Act
As Privacy Awareness Week this year called for individuals to #rebootyourprivacy and debate continues over the privacy protections for the COVIDSafe application, another step has been taken in the Australian Information Commissioner's (Commissioner) landmark case against Facebook, Inc and Facebook Ireland Ltd (together, Facebook) which will have major implications for the Privacy Act 1988 (Cth) (Privacy Act) and digital businesses operating from offshore entities. ...
The AI-generated picture becomes clearer: key legal considerations emerging for generative AI developers and their customers
With rapid developments, it is proving increasingly difficult to stay across the full range of implications for the use and regulation of generative AI tools. This Insight is intended to provide an update on the developments in generative. ...
Guide to addressing ESG impacts in generative AI deployment
This guide outlines key ESG risks and impacts companies deploying AI should consider, the questions they should be asking, and what to do in response. ...
Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...
Takeaways from recent guidance on cyber incident disclosure obligations for listed companies
In this Insight, we examine the guidance note and related developments and offer our view as to when disclosure (for the purposes of the ASX listing rule requirements) of cyber incidents should generally only occur. ...
Media Reform Green Paper
On 27 November, the Department of Communications issued a Media Reform Green Paper (Green Paper) seeking views on a number of proposals. The Green Paper builds on a number of issues highlighted by the ...